跳转至内容
Merck
所有图片(1)

主要文件

NEUR1001

Sigma-Aldrich

Mixed neurons, CTRL Line

IPSC derived

登录查看公司和协议定价


About This Item

UNSPSC代码:
12352200

生物来源

human

表单

liquid

生长模式

Adherent

核型

2n=46

形态学

elongated/polarized, neuronal

运输

dry ice

储存温度

−196°C

细胞系描述

Control line derived from the parental XCL-1, an integration-free iPSC line

应用

These products provide unique and versatile tools for the study of central nervous system (CNS) disorders, such as Alzheimer′s disease (AD), Parkinson′s disease (PD), autism, schizophrenia, and amyotrophic lateral sclerosis (ALS), as well as for drug screening and toxicology applications in the neural space.

特点和优势

This product contains cryo-preserved, pre-differentiated mixed population neurons derived from a footprint-free, karyotype normal human iPSC line. It was designed for customers to generate mature neurons using the optimized maturation medium and supplement (NEUR1050, NEUR1051 sold separately). Mature neurons can be obtained within 8 days. The neurons can be seeded on various culture vessel formats including 96 well plates on either glass or plastic surfaces and cultured as adherent cells. Shortly after seeding, the cells proliferate slightly for up to 3 days and show extensive neurite outgrowth and proper neuronal morphology. In general, at 8 days post-seeding, the cell population will contain ≥98% neurons and ≤1% Glial Fibrillary Acidic Protein (GFAP) positive astrocytes.

培养基

User must also purchase Neuronal Maturation Medium, NEUR1050 (50mL) or NEUR1051 (250mL). Sold separately.

传代培养常规

No subculture routine is necessary. See technical bulletin for additional details.

储存分类代码

10 - Combustible liquids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Anastasia Efthymiou et al.
Journal of biomolecular screening, 19(1), 32-43 (2013-09-11)
Rapid and effective drug discovery for neurodegenerative disease is currently impeded by an inability to source primary neural cells for high-throughput and phenotypic screens. This limitation can be addressed through the use of pluripotent stem cells (PSCs), which can be
Yiping Yan et al.
Stem cells translational medicine, 2(11), 862-870 (2013-10-12)
Human pluripotent stem cells (hPSCs), including human embryonic stem cells and human induced pluripotent stem cells, are unique cell sources for disease modeling, drug discovery screens, and cell therapy applications. The first step in producing neural lineages from hPSCs is

Questions

Reviews

No rating value

Active Filters

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门